Metabolic syndrome in patients suffering from schizophrenia in Mumbai, India� study of demographic, anthropometric and clinical variables

Dr Vanshree Patil Balasinorwala; Dr Nilesh B Shah

Volume : VI, Issue : VII, July - 2016

Metabolic syndrome in patients suffering from schizophrenia in Mumbai, India� study of demographic, anthropometric and clinical variables

Dr Vanshree Patil Balasinorwala, Dr Nilesh B Shah

Abstract :

In India, very few studies have tried to study the association of metabolic syndrome (MS) with demographic, anthropometric and clinical variables among patients suffering from schizophrenia. This study was undertaken to determine the prevalence and evaluate MS in schizophrenia. 133 outpatients attending the psychiatry department of a general hospital in a tier 1 city (Mumbai) in India and suffering from schizophrenia (DSM IV) were evaluated for demographic, anthropometric and clinical variables and presence of MS as per the National Cholesterol Education Program–Adult Treatment Panel III criteria. The prevalence of MS was 18.8% (M: 44%, F: 56%). MS prevalence was statistically significantly higher in female subjects (P=0.043), those over 40 years (P=0.002) and in those suffering from schizophrenia for more than five years (P=0.008). Screening patients for MS by non invasive interventions like waist circumference measurement and preventive measures for MS in patients suffering from schizophrenia is suggested.